CAbS obtains the ISO 9001 certification
Our Custom Antibody Service (CAbS, https://nb4d.csic.es/cabs/), which constitutes the unit 2 of the ICTS NANBIOSIS (https://www.nanbiosis.es/portfolio/u2-custom-antibody-service-cabs/), has achieved the ISO 9001:2015 certification for its service of development and production of monoclonal antibodies. CAbS was created in 2009 under the shared umbrella of CSIC and CIBER-BBN built on the longstanding experience of the Nb4D group in the field of[...]
Nb4D starts 2 new European projects
The year 2024 starts with very good news for the Nb4D group, with the kick-off of two new European projects for the next 4 following years: TAME and TOXBOX. TAME (https://tame-itn.eu/) is the acronym of Doctoral training network TAu imMunE: strategies for innovative diagnosis and therapies in dementia and constitutes the 1st Tau Network of Europe. This project is[...]
Sierra-SPR32 Pro, new laboratory acquisition
We are thrilled to announce the acquisition of a Sierra-SPR32 Pro, an exceptional scientific instrument manufactured by Bruker and designed to perform real-time, label-free, and high-throughput analysis of molecular interactions with high sensitivity and accuracy. SPR stands for Surface Plasmon Resonance, which is a label-free detection technique used to study the interactions between biomolecules, such as proteins, nucleic acids,[...]
Congrats, Dr. Guercetti!
On 25th October 2023 (11:00 h), at Sala d'Actes of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Julian Guercetti obtained his PhD degree after an excellent dissertation of his Thesis entitled "Microarray Strategies for Multiplexed Immunochemical Analysis". The Thesis of Julian was the fruit of a long a nd hard work of more than 4 years in the framework[...]
PhD Defense of Julian Guercetti – 25/10/2023
On 25th October 2023 (11:00 h), at Sala d'Actes of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), our PhD candidate Julian Guercetti will defend his Thesis entitled "Microarray Strategies for Multiplexed Immunochemical Analysis". Julian has developed his work in the framework of two different research lines. Initially, he started working in the context of a Marie Curie Network intended[...]
